Kemira Oyj Stock Exchange Release February 10, 2015 at 8.30 am (CET+1) Following proposals will be submitted to the Annual General Meeting: * Resolution on the use of the profits shown on the balance sheet and on dividends * Remuneration and election of the auditor * Share repurchase authorization * Share issue authorization Proposals of Kemira Oyj's Nomination Board, consisting of the representatives of the four largest shareholders, on the number of members of the Board of Directors and election of the Chairman, the Vice Chairman and the members of the Board of Directors and on the remuneration of the Chairman, the Vice Chairman and the members of the Board of Directors to the Annual General Meeting were published on January 27, 2015. The Annual General Meeting of Kemira Oyj will be held on Monday, March 23, 2015 at 1.00 pm at Finlandia Hall, Congress Wing, Mannerheimintie 13 e, Helsinki, Finland. The invitation will be published on February 26, 2015 in Helsingin Sanomat and on Kemira's website. Resolution on the use of the profit shown on the balance sheet and on dividends The Board of Directors proposes to the Annual General Meeting that a dividend of EUR 0.53 per share be paid based on the adopted balance sheet for the financial year which ended on December 31, 2014. The dividend will be paid to a shareholder who is registered in the company's shareholder register maintained by Euroclear Finland Ltd on the record date for dividend payment, March 25, 2015. The Board of Directors proposes that the dividend be paid out on April 1, 2015. Resolution on the remuneration of the auditor The Board of Directors proposes to the Annual General Meeting on the recommendation of the Audit Committee, that the Auditor's fees be paid against an invoice approved by Kemira. Election of the auditor The Board of Directors proposes to the Annual General Meeting on the recommendation of the Audit Committee, that Deloitte & Touche Oy be elected as the company's auditor with Jukka Vattulainen, APA, acting as the principal auditor. Proposal of the Board of Directors for authorizing the Board of Directors to decide on the repurchase of the company's own shares The Board of Directors proposes that the Annual General Meeting authorizes the Board of Directors to decide upon repurchase of a maximum of 4,500,000 company's own shares ("Share repurchase authorization"). Shares will be repurchased by using unrestricted equity either through a tender offer with equal terms to all shareholders at a price determined by the Board of Directors or otherwise than in proportion to the existing shareholdings of the company's shareholders in public trading on the NASDAQ OMX Helsinki Ltd (the "Helsinki Stock Exchange") at the market price quoted at the time of the repurchase. The price paid for the shares repurchased through a tender offer under the authorization shall be based on the market price of the company's shares in public trading. The minimum price to be paid would be the lowest market price of the share quoted in public trading during the authorization period and the maximum price the highest market price quoted during the authorization period. Shares shall be acquired and paid for in accordance with the Rules of the Helsinki Stock Exchange and Euroclear Finland Ltd. Shares may be repurchased to be used in implementing or financing mergers and acquisitions, developing the company's capital structure, improving the liquidity of the company's shares or to be used for the payment of the annual fee payable to the members of the Board of Directors or implementing the company's share-based incentive plans. In order to realize the aforementioned purposes, the shares acquired may be retained, transferred further or cancelled by the company. The Board of Directors will decide upon other terms related to share repurchase. The Share repurchase authorization is valid until the end of the next Annual General Meeting. Proposal of the Board of Directors for authorizing the Board of Directors to decide on share issue The Board of Directors proposes that the Annual General Meeting authorizes the Board of Directors to decide to issue a maximum of 15,600,000 new shares and transfer a maximum of 7,800,000 company's own shares held by the company ("Share issue authorization"). The new shares may be issued and the company's own shares held by the company may be transferred either for consideration or without consideration. The new shares may be issued and the company's own shares held by the company may be transferred to the company's shareholders in proportion to their current shareholdings in the company, or by disapplying the shareholders' pre-emption right, through a directed share issue, if the company has a weighty financial reason to do so, such as financing or implementing mergers and acquisitions, developing the capital structure of the company, improving the liquidity of the company's shares or if this is justified for the payment of the annual fee payable to the members of the Board of Directors or implementing the company's share-based incentive plans. The directed share issue may be carried out without consideration only in connection with the implementation of the company's share- based incentive plan. The subscription price of new shares shall be recorded to the invested unrestricted equity reserves. The consideration payable for company's own shares shall be recorded to the invested unrestricted equity reserves. The Board of Directors will decide upon other terms related to the share issues. The Share issue authorization is valid until May 31, 2016. For more information, please contact Kemira Oyj Jukka Hakkila, Group General Counsel +358 10 862 1690 Tero Huovinen, VP, Investor Relations +358 10 862 1980 Kemira is a global chemicals company serving customers in water-intensive industries. We provide expertise, application know-how and chemicals that improve our customers' water, energy and raw material efficiency. Our focus is on pulp & paper, oil & gas, mining and water treatment. In 2014, Kemira had annual revenue of EUR 2.1 billion and around 4,250 employees. Kemira shares are listed on the NASDAQ OMX Helsinki Ltd. www.kemira.com [HUG#1892821]
Kemira Oyj: Proposals of the Board of Directors to the
Top 10 Most Recent News Articles
FDA Greenlights Halozyme's Cancer Treatment Breakthrough
FDA's Seal of Approval: A Game Changer Well, folks, here's a twist in the story of cancer treatment with FDA giving a nod to RYBREVANT FASPRO. Johnson & Johnson's latest offering, fueled by Halozyme's groundbreaking ENHANZE technology, just snagged accelerated approval. We're not just talking any old treatment here; it's a dual-targeted therapy for head and neck cancer...
Continue Reading
Investor Bidding on Off-Market Homes Surges 35% Higher
Investor Frenzy in Off-Market Real Estate Looking at the real estate puzzle today, one might spot an unexpected surge in enthusiasm for off-market residential properties. We've got iFinder Offers, a real estate platform that's made it its business to connect the dots between homeowners and a gaggle of over 325 hungry investors. And according to their magic spreadsheets,...
Continue Reading
CalExitNow Push for CA GOP Ban & Sovereignty Talks
California's Political Pot Stirs In the wild world of politics, California stands as a fiery beacon yet again. This time, CalExitNow, a fiery group championing California's self-determination, is taking aim at the state’s Republican Party. Reminds me of a stock under pressure—hesitate at your peril as the winds of change sweep through. Disqualification Petition: A...
Continue Reading
INOVIO's $75M Offering: A Tough Medicine for Investors
A Shot in the Arm or a Sore Spot? INOVIO Pharmaceuticals is diving headfirst into the capital markets with a $75 million public offering, and let me tell you, the road ahead isn't paved with gold, yet. They've set out to raise funds by pricing 58,747,235 shares at $1.05 a pop, which might have you scratching your head if you're holding INO shares already. Breaking Down...
Continue Reading
AiNET Prevails in Breach of Contract Jury Verdict
AiNET's Legal Triumph Shakes Up the IT Sector Well, talk about a courtroom drama. Greenberg Traurig just snagged a big win for AiNET over in Prince George's County, Maryland, and it's a classic reminder that due diligence isn't just a nice-to-have—it's a must. AiNET found itself in the center of a breach of contract brawl with Tech Finance Co., and guess what? The jury...
Continue Reading
Lilly's Digital Healthcare Push with Hims & Hers
Revolutionizing Access: Pharmaceuticals Meet Telehealth In an era where digital disruption is shaking every sector, Eli Lilly (NYSE:LLY) isn't sitting idle. They've just forged a partnership with Hims & Hers (NYSE:HIMS), one that's diving headfirst into the telehealth revolution. We're talking a slick merger of pharmaceuticals and digital platforms—offering FDA-approved...
Continue Reading
Everest Group Faces Class Action: Key Investor Moves
Everest Group's Legal Spiral: What's Happening? Folks, when a company feels like it's caught in an endless storm, investors better hold on tight. That's the situation Everest Group, Ltd. finds itself in, with an 11.4% stock dive that’s got investors reeling. Securities fraud allegations are rocking Everest like a hurricane, and The Law Offices of Frank R. Cruz have put...
Continue Reading
Brian Long Exits Atlantic Bridge for US Tech Fund
Well, here we go again with another shake-up in the tech investment world. Brian Long, a name that's been whispered around more than a few boardroom tables, is dropping out of Atlantic Bridge to start his own gig across the pond in the United States. If you're tracking numbers, Atlantic Bridge is juggling a healthy €1.4bn in assets—no small potatoes. So, let's dig...
Continue Reading
LaserAway Opens 241st Clinic, Marks 20-Year Milestone
LaserAway's New Chapter in Paramus Out of the glitz of Los Angeles and into the hustle of Paramus, LaserAway's latest clinic isn't just a ribbon-cutting ceremony—it's a milestone in the aesthetic dermatology space. Boasting its 241st location, LaserAway is marking twenty years of relentless expansion without ever closing a single clinic. Now that's a track record that'd...
Continue Reading
TELUS Targets Debt Reduction Amid Telecom Transformation
Adjusting Strategy Amid Financial Challenges The market's a tough beast, and TELUS seems to be wrestling with it, showing both grit and foresight in its latest quarterly update. Third quarter 2026 has TELUS down on revenues with a notable net loss but don't count them out yet. Their Transformation Strategy is a gamble worth watching. Where the Numbers Stand Here's the...
Continue ReadingTop 5 Most Recently Viewed Articles
Jersey Mike's Subs Goes Public with Tasty IPO Plans
Alright, so here's the deal with Jersey Mike's Subs. These folks are storming into the stock market with an IPO that's about to get everyone talking. They're offering a meaty stack of shares—43,478,261 to be exact—hoping to lure investors into a world where sandwiches aren't just a food item, but an experience. Slide into that booth and get your wild predictions...
Continue Reading
Unlocking AI Potential: MicroStrategy's Latest Innovations
MicroStrategy's New Release Enhances AI Personalization MicroStrategy Incorporated (NASDAQ: MSTR), renowned for revolutionizing business intelligence through AI, has unveiled an innovative update to MicroStrategy ONE. This cutting-edge release is designed to help organizations quickly extract value from generative AI (GenAI), tailoring the AI experience to meet the...
Continue Reading
Explore Orbit Local's Revolutionary AI-Driven Marketing Solutions
Unlocking Business Potential with AI-Driven Solutions Orbit Local proudly introduces an innovative Marketing Automation and CRM platform powered by Artificial Intelligence. This robust solution is crafted to assist businesses in enhancing lead generation, improving customer engagement, and ultimately driving sales. With a seamless integration of automation features, AI...
Continue Reading
HORNE Foundation Delivers Generous Support for Charities
HORNE Community Foundation Gives Back to Four Non-Profits $100,000 in total giving benefits organizations from across the United States. Recently, HORNE, a professional services firm, demonstrated its commitment to community support by announcing generous donations to four charities. These contributions, fulfilling specific missions, total $100,000 and aid organizations...
Continue Reading
Surge in Solar Energy Market in Canada Driven by Innovation
Significant Growth in the Solar Energy Market The solar energy market in Canada is experiencing remarkable evolution, with projections indicating an increase in size by approximately USD 2.25 billion during the period from 2025 to 2029. This growth is driven primarily by government initiatives and increasing acceptance of solar power as a viable and sustainable energy...
Continue Reading